| 1 |
Kouroumalis E, Tsomidis I, Voumvouraki A. Iron as a therapeutic target in chronic liver disease. World J Gastroenterol 2023; 29(4): 616-655 [DOI: 10.3748/wjg.v29.i4.616] [Reference Citation Analysis]
|
| 2 |
Gorgis N, Desai MS. Cardiovascular dysfunction in liver diseases: pediatric perspectives. Cardio-Hepatology 2023. [DOI: 10.1016/b978-0-12-817394-7.00013-9] [Reference Citation Analysis]
|
| 3 |
Sá GCDS, da Silva LB, Bezerra PVV, da Silva MAF, Inacio CLS, Paiva WS, E Silva VPM, Cordeiro LV, Oliveira JWF, Silva MS, Lima EO, Moreira FJC, Rocha HAO, Barra PB, Ximenes MFFM, Uchôa AF. Tephrosia toxicaria (Sw.) Pers. extracts: Screening by examining aedicidal action under laboratory and field conditions along with its antioxidant, antileishmanial, and antimicrobial activities. PLoS One 2023;18:e0275835. [PMID: 36630475 DOI: 10.1371/journal.pone.0275835] [Reference Citation Analysis]
|
| 4 |
Jia FJ, Han J. Liver injury in COVID-19: Holds ferritinophagy-mediated ferroptosis accountable. World J Clin Cases 2022; 10(36): 13148-13156 [DOI: 10.12998/wjcc.v10.i36.13148] [Reference Citation Analysis]
|
| 5 |
Teschke R. Aluminum, Arsenic, Beryllium, Cadmium, Chromium, Cobalt, Copper, Iron, Lead, Mercury, Molybdenum, Nickel, Platinum, Thallium, Titanium, Vanadium, and Zinc: Molecular Aspects in Experimental Liver Injury. IJMS 2022;23:12213. [DOI: 10.3390/ijms232012213] [Reference Citation Analysis]
|
| 6 |
Fernandez M, Lokan J, Leung C, Grigg A. A critical evaluation of the role of iron overload in fatty liver disease. J Gastroenterol Hepatol 2022;37:1873-83. [PMID: 35906772 DOI: 10.1111/jgh.15971] [Reference Citation Analysis]
|
| 7 |
Liu Z, Suo C, Jiang Y, Zhao R, Zhang T, Jin L, Chen X. Phenome-Wide Association Analysis Reveals Novel Links Between Genetically Determined Levels of Liver Enzymes and Disease Phenotypes. Phenomics 2022;2:295-311. [PMID: 36939802 DOI: 10.1007/s43657-021-00033-y] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 8 |
Ali N, Ferrao K, Mehta KJ. Liver Iron Loading in Alcohol-Associated Liver Disease. The American Journal of Pathology 2022. [DOI: 10.1016/j.ajpath.2022.08.010] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 9 |
Chen H. Iron metabolism in nonalcoholic fatty liver disease: a promising therapeutic target. Liver Research 2022. [DOI: 10.1016/j.livres.2022.09.003] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 10 |
Horeau M, Ropert M, Mulder E, Tank J, Frings-Meuthen P, Armbrecht G, Loréal O, Derbré F. Iron Metabolism Regulation in Females and Males Exposed to Simulated Microgravity: results from the Randomized Trial AGBRESA. Am J Clin Nutr 2022:nqac205. [PMID: 36026525 DOI: 10.1093/ajcn/nqac205] [Reference Citation Analysis]
|
| 11 |
Bloomer SA. Hepatic Macrophage Abundance and Phenotype in Aging and Liver Iron Accumulation. Int J Mol Sci 2022;23:6502. [PMID: 35742946 DOI: 10.3390/ijms23126502] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 12 |
Wang H, Jiang C, Yang Y, Li J, Wang Y, Wang C, Gao Y. Resveratrol ameliorates iron overload induced liver fibrosis in mice by regulating iron homeostasis. PeerJ 2022;10:e13592. [PMID: 35698613 DOI: 10.7717/peerj.13592] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 13 |
Li Y, Jiang W, Feng Y, Wu L, Jia Y, Zhao R. Betaine Alleviates High-Fat Diet-Induced Disruptionof Hepatic Lipid and Iron Homeostasis in Mice. Int J Mol Sci 2022;23:6263. [PMID: 35682942 DOI: 10.3390/ijms23116263] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 14 |
Silva AMN, Rangel M. The (Bio)Chemistry of Non-Transferrin-Bound Iron. Molecules 2022;27:1784. [PMID: 35335148 DOI: 10.3390/molecules27061784] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 15 |
Jiao L, Dai T, Lu J, Tao X, Jin M, Sun P, Zhou Q. Excess iron supplementation induced hepatopancreas lipolysis, destroyed intestinal function in Pacific white shrimp Litopenaeus vannamei. Mar Pollut Bull 2022;176:113421. [PMID: 35183027 DOI: 10.1016/j.marpolbul.2022.113421] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 16 |
Kouroumalis E, Voumvouraki A. Hepatitis C virus: A critical approach to who really needs treatment. World J Hepatol 2022; 14(1): 1-44 [DOI: 10.4254/wjh.v14.i1.1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 17 |
Wang K, Yang F, Zhang P, Yang Y, Jiang L. Genetic effects of iron levels on liver injury and risk of liver diseases: A two-sample Mendelian randomization analysis. Front Nutr 2022;9:964163. [PMID: 36185655 DOI: 10.3389/fnut.2022.964163] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 18 |
Videla LA, Valenzuela R. Perspectives in liver redox imbalance: Toxicological and pharmacological aspects underlying iron overloading, nonalcoholic fatty liver disease, and thyroid hormone action. Biofactors 2021. [PMID: 34687092 DOI: 10.1002/biof.1797] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 19 |
Shen ZY, He CL, Sun Q, Zhang S, Hu LL, Liu QH, Zhang H, Liu X, Miao YQ, Gu WY, Wang F, Wang CL, Shi YY, Wang L, Jiao J, Ye JJ, Xu LY, Yan DM, Li ZY, Jin YL, Huang SP, Xu KL, Sang W. [Clinical prognostic analysis of 124 adult patients with hemophagocytic lymphohistiocytosis: a multicenter retrospective study of the Huaihai Lymphoma Working Group]. Zhonghua Xue Ye Xue Za Zhi 2021;42:800-6. [PMID: 34788918 DOI: 10.3760/cma.j.issn.0253-2727.2021.10.002] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 20 |
Petrillo S, Manco M, Altruda F, Fagoonee S, Tolosano E. Liver Sinusoidal Endothelial Cells at the Crossroad of Iron Overload and Liver Fibrosis. Antioxid Redox Signal 2021;35:474-86. [PMID: 32689808 DOI: 10.1089/ars.2020.8168] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 21 |
Jia M, Zhang H, Qin Q, Hou Y, Zhang X, Chen D, Zhang H, Chen Y. Ferroptosis as a new therapeutic opportunity for nonviral liver disease. Eur J Pharmacol 2021;908:174319. [PMID: 34252441 DOI: 10.1016/j.ejphar.2021.174319] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 22 |
Lu X, Li J, Lou H, Cao Z, Fan X. Genome-Wide DNA Methylation Alterations and Potential Risk Induced by Subacute and Subchronic Exposure to Food-Grade Nanosilica in Mice. ACS Nano 2021;15:8225-43. [PMID: 33938728 DOI: 10.1021/acsnano.0c07323] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 23 |
Del Nonno F, Nardacci R, Colombo D, Visco-Comandini U, Cicalini S, Antinori A, Marchioni L, D'Offizi G, Piacentini M, Falasca L. Hepatic Failure in COVID-19: Is Iron Overload the Dangerous Trigger? Cells 2021;10:1103. [PMID: 34064487 DOI: 10.3390/cells10051103] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 24 |
Zhu Y, Zhang C, Huang M, Lin J, Fan X, Ni T. TRIM26 Induces Ferroptosis to Inhibit Hepatic Stellate Cell Activation and Mitigate Liver Fibrosis Through Mediating SLC7A11 Ubiquitination. Front Cell Dev Biol 2021;9:644901. [PMID: 33869196 DOI: 10.3389/fcell.2021.644901] [Cited by in Crossref: 11] [Cited by in F6Publishing: 16] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 25 |
Chen HJ, Sugiyama M, Shimokawa F, Murakami M, Hashimoto O, Matsui T, Funaba M. Response to iron overload in cultured hepatocytes. Sci Rep 2020;10:21184. [PMID: 33273573 DOI: 10.1038/s41598-020-78026-6] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 26 |
Marin-alejandre BA, Abete I, Monreal JI, Elorz M, Benito-boillos A, Herrero JI, Navarro-blasco I, Tur JA, Bandarra NM, Zulet MA, Martinez JA. Effects of a 6-month dietary-induced weight loss on erythrocyte membrane omega-3 fatty acids and hepatic status of subjects with nonalcoholic fatty liver disease: The Fatty Liver in Obesity study. Journal of Clinical Lipidology 2020;14:837-849.e2. [DOI: 10.1016/j.jacl.2020.08.007] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 27 |
Wang Q, Xiao H, Yu X, Lin H, Yang B, Zhang Y, Feng D, Yan F, Wang H. R1ρ at high spin-lock frequency could be a complementary imaging biomarker for liver iron overload quantification. Magn Reson Imaging 2021;75:141-8. [PMID: 33129937 DOI: 10.1016/j.mri.2020.10.014] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 28 |
Dawood RM, El-meguid MA, Salum GM, El Awady MK. Key Players of Hepatic Fibrosis. Journal of Interferon & Cytokine Research 2020;40:472-89. [DOI: 10.1089/jir.2020.0059] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 29 |
Martín-gonzález C, Pelazas-gonzález R, Fernández-rodríguez C, Alemán-valls R, Martínez-riera A, Ortega-toledo P, García-rodríguez A, Rodríguez-gaspar M, González-reimers E. Ferritin and liver fibrosis among patients with chronic hepatitis C virus infection. Journal of Trace Elements in Medicine and Biology 2020;61:126542. [DOI: 10.1016/j.jtemb.2020.126542] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 30 |
Zhou J, Zhou J, Wu ZQ, Goyal H, Xu HG. A novel prognostic model for adult patients with Hemophagocytic Lymphohistiocytosis. Orphanet J Rare Dis 2020;15:215. [PMID: 32819431 DOI: 10.1186/s13023-020-01496-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 31 |
Gautheron J, Gores GJ, Rodrigues CMP. Lytic cell death in metabolic liver disease. J Hepatol 2020;73:394-408. [PMID: 32298766 DOI: 10.1016/j.jhep.2020.04.001] [Cited by in Crossref: 72] [Cited by in F6Publishing: 75] [Article Influence: 24.0] [Reference Citation Analysis]
|
| 32 |
Seeßle J, Gan-Schreier H, Kirchner M, Stremmel W, Chamulitrat W, Merle U. Plasma Lipidome, PNPLA3 polymorphism and hepatic steatosis in hereditary hemochromatosis. BMC Gastroenterol 2020;20:230. [PMID: 32680469 DOI: 10.1186/s12876-020-01282-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 33 |
Orisakwe OE, Amadi CN, Frazzoli C. Management of Iron Overload in Resource Poor Nations: A Systematic Review of Phlebotomy and Natural Chelators. J Toxicol 2020;2020:4084538. [PMID: 32399029 DOI: 10.1155/2020/4084538] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 34 |
Ribot-Hernández I, Martín-González C, Vera-Delgado V, González-Navarrete L, de Armas-González JF, Viña-Rodríguez J, Sánchez-Pérez MJ, Rodríguez-Gaspar M, González-Reimers E. Prognostic Value of Serum Iron, Ferritin, and Transferrin in Chronic Alcoholic Liver Disease. Biol Trace Elem Res 2020;195:427-35. [PMID: 31486016 DOI: 10.1007/s12011-019-01887-0] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
|
